This NDC is on FDA's drug shortage list (posted Feb 8, 2019)
Product Information
DEXAMETHASONE 20 MG/5 ML VIAL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.3899 per ML under NDC 00641614625. Its NADAC has been published 111 times since May 20, 2020.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AP.
Strength
4 mg/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00641614625
Classification
Generic
Dosage Form
INJECTION
Route
INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE
Effective Date
12/18/2024
Active Ingredients
DEXAMETHASONE SODIUM PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA084282FDA Approved
Before 1982
TE Code
AP
On Market Since
7/15/1975
Pharmacological Classes
Price Statistics
The NADAC for DEXAMETHASONE 20 MG/5 ML VIAL has been published 111 times since May 20, 2020, and over the history we have for it it has risen 141.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3899 per ML |
|---|---|
| All-time high | $0.3899 (May 28, 2025) |
| All-time low | $0.1616 (May 20, 2020) |
| Median price | $0.1807 |
| Average price | $0.2546 |
| Largest weekly change | +61.9% (Jun 19, 2024) |
| Weeks tracked | 111 |
| Tracking since | May 20, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+141.3%
5Y
+141.3%
All
+141.3%
Last surveyed May 28, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 48% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXAMETHASONE 20 MG/5 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for DEXAMETHASONE 20 MG/5 ML VIAL, manufactured by Hikma Pharmaceuticals USA Inc., is $0.3899 per ML (NDC 00641614625), effective May 28, 2025.
How has the price of DEXAMETHASONE 20 MG/5 ML VIAL changed over time?
Over the history we have for it, the NADAC for DEXAMETHASONE 20 MG/5 ML VIAL has risen 141.3%. It has been tracked across 111 weekly CMS publications since May 20, 2020.
What are the highest and lowest recorded NADAC prices for DEXAMETHASONE 20 MG/5 ML VIAL?
Since May 20, 2020, the NADAC for DEXAMETHASONE 20 MG/5 ML VIAL has ranged from a low of $0.1616 (May 20, 2020) to a high of $0.3899 (May 28, 2025), with a median of $0.1807 per ML.
Are there cheaper alternatives to DEXAMETHASONE 20 MG/5 ML VIAL?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXAMETHASONE 20 MG/5 ML VIAL, is $0.2014 per ML — about 48% below DEXAMETHASONE 20 MG/5 ML VIAL.
Who manufactures DEXAMETHASONE 20 MG/5 ML VIAL?
DEXAMETHASONE 20 MG/5 ML VIAL (NDC 00641614625) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Is DEXAMETHASONE 20 MG/5 ML VIAL in shortage?
Yes — NDC 00641614625 is currently listed in FDA's drug shortage database (posted Feb 8, 2019).